참고문헌
- Cambau E, Allerheiligen V, Coulon C, et al (2009). Evaluation of a New Test, GenoType HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol, 47, 3600-07. https://doi.org/10.1128/JCM.00744-09
- Dixon MF (1991). Helicobacter pylori and peptic ulceration: Histopathological aspect. J Gastroenterol Hepatol, 6, 125-30. https://doi.org/10.1111/j.1440-1746.1991.tb01451.x
- Hopkins RJ, Girardi LS, Turney EA (1996). Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology, 110, 1244-52. https://doi.org/10.1053/gast.1996.v110.pm8613015
- KM Fock, NJ Talley, U Kachintorn, et al (2009). Second Asia Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterology and Hepatology, 24, 1587-600. https://doi.org/10.1111/j.1440-1746.2009.05982.x
- Nguyen LT, Mai HM, Ta L, (2011). Helicobacter pylori infection and gastroduodenal disease in Vietnam. Helicobacter Research, 15, 220-27.
- Malfertheiner P, Megraud F, O'Morain C, et al (2007). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 56, 772-81. https://doi.org/10.1136/gut.2006.101634
- Malfertheiner P, Megraud F, O'Morain C, et al (2012). Management of Helicobacter pylori infection-the maastricht IV/ florence consensus report. Gut, 61, 646-64. https://doi.org/10.1136/gutjnl-2012-302084
- Megraud F (2004). Helicobacter pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut, 53, 1374-84. https://doi.org/10.1136/gut.2003.022111
- Megraud, F., and Lehours P (2007). Helicobacter pylori detection and antimicrobial susceptibility testing. ClinMicrobiol Rev, 20, 280-322.
- Moore, R. A, B. Beckthold, S. Wong, et al (1995). Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother, 39, 107-111. https://doi.org/10.1128/AAC.39.1.107
- Prapitpaiboon H, Mahachai V, Vilaichone RK (2015). High efficacy of levofloxacin-dexlansoprazole-based quadruple therapy as a first line treatment for Helicobacter pylori Eradication in Thailand. Asian Pac J Cancer Prev, 16, 4353-6. https://doi.org/10.7314/APJCP.2015.16.10.4353
- Parsonnet J, Friedman GD, Vandersteen DP, et al (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Eng J Med, 325, 1127-31. https://doi.org/10.1056/NEJM199110173251603
- Perez Aldan L, Kato M, Nakagawa S, et al (2002). The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter, 7, 306-9. https://doi.org/10.1046/j.1523-5378.2002.00096.x
- Rasachak B, Bounkong S (2000). Epidemiologic and endoscopic aspects of Helicobacter pylori infection in Vientian Laos. Bull Soc Pathol Exot, 93, 91-4.
- Srinarong C, Mahachai V, Vilaichone RK (2014). High efficacy of 14-day standard triple therapy plus bismuth with probiotic supplement for Helicobacter pylori eradication in low clarithromycin resistance areas. Asian Pac J Cancer Prev, 15, 9909-13. https://doi.org/10.7314/APJCP.2014.15.22.9909
- Tankovic, JC, Lascols, Q, Sculo JC, et al (2003). Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother, 47, 3942-44. https://doi.org/10.1128/AAC.47.12.3942-3944.2003
- Tytgat GNJ, Noach LA, Rauws EAJ (1993). Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am, 22, 127-39.
- Vannarath S, Vilaichone RK, Rasachak B, et al (2014). Virulence genes of Helicobacter pylori in gastritis, peptic ulcer and gastric cancer in Laos. Asian Pac J Cancer Prev, 15, 9027-31. https://doi.org/10.7314/APJCP.2014.15.20.9027
- Vilaichone RK, Gumnarai P, Ratanachuek T, et al (2013). Nationwide survey of Helicobacter pylori antibiotic resistance in Thailand. Diagnostic Microbiology Infectious Disease, 77, 346-49. https://doi.org/10.1016/j.diagmicrobio.2013.08.010
- Vilaichone RK, Mahachai V, Graham DY (2006). Helicobacter pylori: diagnosis and management. Gastroenterol Clin North Am, 35, 229-47. https://doi.org/10.1016/j.gtc.2006.03.004
- Vilaichone RK, Panarat W, Aekpongpaisit S, et al (2014). Clinical characteristics and Helicobacter pylori status of gastric cancer in Thailand. Asian Pac J Cancer Prev, 15, 9005-8. https://doi.org/10.7314/APJCP.2014.15.20.9005
- Vilaichone RK, Prapitpaiboon H, Gamnarai P, et al (2015). Seven-day bismuth-based quadruple therapy as an initial treatment for Helicobacter pylori infection in a high metronidazole resistant Area. Asian Pac J Cancer Prev, 16, 6089-92. https://doi.org/10.7314/APJCP.2015.16.14.6089
- Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al (1999). Helicobacter pylori associated gastritis and primary B-cell lymphoma. Lancet, 338, 1175-6.